Biomarkers of Myocardial Stress and Systemic Inflammation in Patients Who Engage in Heart Failure Self-care Management
暂无分享,去创建一个
B. Riegel | D. Moser | K. Margulies | Christopher S. Lee | T. Lennie | Terry A Lennie | Debra K Moser | Barbara Riegel | Kenneth B Margulies | N. Tkacs | Christopher S Lee | Nancy C Tkacs
[1] G. Schuler,et al. Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure , 2003, European journal of heart failure.
[2] D. Fliser,et al. Antiinflammatory Effects of Angiotensin II Subtype 1 Receptor Blockade in Hypertensive Patients With Microinflammation , 2004, Circulation.
[3] C. Musil,et al. Recurrent symptoms: well-being and management. , 2001, Social science & medicine.
[4] K. Lorig,et al. Self-management education: History, definition, outcomes, and mechanisms , 2003, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.
[5] B. Riegel,et al. Gender differences in and factors related to self-care behaviors: a cross-sectional, correlational study of patients with heart failure. , 2008, International journal of nursing studies.
[6] M. Emdin,et al. The Circulating Levels of Cardiac Natriuretic Hormones in Healthy Adults: Effects of Age and Sex , 2002, Clinical chemistry and laboratory medicine.
[7] S. Stewart,et al. Measuring Self-care in Chronic Heart Failure: A Review of the Psychometric Properties of Clinical Instruments , 2009, The Journal of cardiovascular nursing.
[8] G. Torre-Amione. Immune activation in chronic heart failure. , 2005, The American journal of cardiology.
[9] H. Ruskoaho. Cardiac hormones as diagnostic tools in heart failure. , 2003, Endocrine reviews.
[10] Haske van Veenendaal,et al. Effectiveness of self-management interventions on mortality , hospital readmissions , chronic heart failure hospitalization rate and quality of life in patients with chronic heart failure : A systematic review , 2010 .
[11] M. Drazner,et al. Impact of Body Mass and Body Composition on Circulating Levels of Natriuretic Peptides: Results From the Dallas Heart Study , 2005, Circulation.
[12] R. Dantzer,et al. Named Series: Twenty Years of Brain, Behavior, and Immunity Twenty years of research on cytokine-induced sickness behavior , 2007 .
[13] J. Cohn,et al. Relationships between clinical assessments and patients' perceptions of the effects of heart failure on their quality of life. , 2006, Journal of cardiac failure.
[14] J. H. Patterson,et al. Executive Summary Executive Summary : HFSA 2010 Comprehensive Heart Failure Practice Guideline , 2022 .
[15] G. Novo,et al. Biomarkers in heart failure. , 2009, Frontiers in bioscience.
[16] B. Riegel,et al. A Situation-Specific Theory of Heart Failure Self-care , 2008, The Journal of cardiovascular nursing.
[17] B. Riegel,et al. The Influence of Heart Failure Self-care on Health Outcomes: Hypothetical Cardioprotective Mechanisms , 2009, The Journal of cardiovascular nursing.
[18] A. Ferreira,et al. The effect of dietary sodium restriction on neurohumoral activity and renal dopaminergic response in patients with heart failure , 2004, European journal of heart failure.
[19] V. Hasselblad,et al. Dissociation between hemodynamic changes and symptom improvement in patients with advanced congestive heart failure , 2002, European journal of heart failure.
[20] A. Ferreira,et al. Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure. , 2004, International journal of cardiology.
[21] J. Morrow,et al. Intraindividual Variability of Plasma Antioxidants, Markers of Oxidative Stress, C-Reactive Protein, Cotinine, and Other Biomarkers , 2006, Epidemiology.
[22] L. Allen,et al. Multi-marker strategies in heart failure: clinical and statistical approaches , 2010, Heart Failure Reviews.
[23] D. Morrow,et al. Benchmarks for the Assessment of Novel Cardiovascular Biomarkers , 2007, Circulation.
[24] M. Packer. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. , 1992, Journal of the American College of Cardiology.
[25] L. Appel,et al. State of the science: promoting self-care in persons with heart failure: a scientific statement from the American Heart Association. , 2009, Circulation.
[26] Anders Larsson,et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. , 2008, The New England journal of medicine.
[27] W. Shadish,et al. Experimental and Quasi-Experimental Designs for Generalized Causal Inference , 2001 .
[28] S. Frøland,et al. Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure. , 1999, Journal of the American College of Cardiology.
[29] B. Bozkurt,et al. Basic mechanisms in heart failure: the cytokine hypothesis. , 1996, Journal of cardiac failure.
[30] J. V. D. van den Ouweland,et al. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. , 2004, Clinical chemistry.
[31] M. Sebern,et al. Psychometric testing of the self-care of heart failure index. , 2004, Journal of cardiac failure.
[32] B. Riegel,et al. Abstract 2510: Nonadherence is a Mediator of the Link Between Depressive Symptoms, and Rehospitalization or Mortality in Patients with Heart Failure , 2006 .
[33] R. Tate,et al. Determinants of Self-care Behaviors in Community-Dwelling Patients With Heart Failure , 2009, The Journal of cardiovascular nursing.
[34] R. Dantzer,et al. Cytokine-induced sickness behavior , 2003, Brain, Behavior, and Immunity.
[35] S. Anker,et al. Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure , 2000, Circulation.
[36] N. Khaper,et al. Inflammatory cytokines and postmyocardial infarction remodeling. , 2004, Circulation research.
[37] Stephan von Haehling,et al. Inflammatory mediators in chronic heart failure: an overview , 2004, Heart.
[38] J. Heywood,et al. Optimal use of diuretics in patients with heart failure , 2007, Current treatment options in cardiovascular medicine.
[39] A. Kızıltunç,et al. The Effect of Beta‐Blocker (Carvedilol) Therapy on N‐Terminal Pro‐Brain Natriuretic Peptide Levels and Echocardiographic Findings in Patients with Congestive Heart Failure , 2007, Echocardiography.
[40] K. Dickstein,et al. Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients. , 2005, Journal of the American College of Cardiology.
[41] P. Allison. Multiple Regression: A Primer , 1994 .
[42] M. Nieminen,et al. Clinical applications of B-type natriuretic peptide (BNP) testing. , 2003, European heart journal.
[43] J. Ulrich. [Physiology of the heart]. , 1950, Zeitschrift fur Kreislaufforschung.
[44] B. Riegel,et al. The Relationship Between Self-Care and Health Status Domains in Thai Patients with Heart Failure , 2009, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.
[45] A. Hoffmeier,et al. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[46] B. Riegel,et al. Event-free survival in adults with heart failure who engage in self-care management. , 2011, Heart & lung : the journal of critical care.
[47] J. Thornby,et al. Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials. , 1999, Journal of the American College of Cardiology.
[48] B. Riegel,et al. Predictors of self-care in persons with heart failure. , 1999, Heart & lung : the journal of critical care.
[49] T. Ueland,et al. Inflammatory and anti‐inflammatory cytokines in chronic heart failure: Potential therapeutic implications , 2005, Annals of medicine.
[50] Anita Deswal,et al. Cytokines and Cytokine Receptors in Advanced Heart Failure: An Analysis of the Cytokine Database from the Vesnarinone Trial (VEST) , 2001, Circulation.
[51] S. Rajagopalan,et al. Statin therapy is associated with improved cardiovascular outcomes and levels of inflammatory markers in patients with heart failure. , 2005, Journal of cardiac failure.
[52] J. Goetze. Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited. , 2004, Clinical chemistry.
[53] A. Jaffe,et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biomarkers of heart failure. , 2007, Clinical biochemistry.
[54] Harleah G. Buck,et al. "Determinants of self-care behaviors in community-dwelling patients with heart failure". , 2009, The Journal of cardiovascular nursing.
[55] I. Squire,et al. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate , 2003, European journal of heart failure.
[56] C. Zambroski. Self-care at the End of Life in Patients With Heart Failure , 2008, The Journal of cardiovascular nursing.
[57] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.
[58] F. van Lente,et al. Plasma B-Type Natriuretic Peptide Levels in Ambulatory Patients With Established Chronic Symptomatic Systolic Heart Failure , 2003, Circulation.